No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Shareholders in SomnoMed (ASX:SOM) Are in the Red If They Invested Five Years Ago
SomnoMed Target Price Raised 7.1% to A$0.45/Share by Wilsons>SOM.AU
SomnoMed Upgrades Fiscal 2025 Revenue, EBITDA Guidance; Shares Soar 41%
SomnoMed Ltd: FY25 Guidance Upgrade and Appointment of CFO
Somnomed Wins US FDA Clearance for Sleep Disorder Product; Shares Jump 5%
SomnoMed Ltd: Annual Report to shareholders
No Data